BRPI0517672A - modalidades de formação de imagens para seleção terapêutica de doença de alzheimer - Google Patents

modalidades de formação de imagens para seleção terapêutica de doença de alzheimer

Info

Publication number
BRPI0517672A
BRPI0517672A BRPI0517672-7A BRPI0517672A BRPI0517672A BR PI0517672 A BRPI0517672 A BR PI0517672A BR PI0517672 A BRPI0517672 A BR PI0517672A BR PI0517672 A BRPI0517672 A BR PI0517672A
Authority
BR
Brazil
Prior art keywords
alzheimer
disease
imaging modalities
therapeutic selection
therapeutic
Prior art date
Application number
BRPI0517672-7A
Other languages
English (en)
Inventor
Julia L Rutkowski
Jack Steven Jacobsen
Orest Hurko
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0517672A publication Critical patent/BRPI0517672A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A01K2267/0312—Animal model for Alzheimer's disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Biomedical Technology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)

Abstract

MODALIDADES DE FORMAçãO DE IMAGENS PARA SELEçãO TERAPêUTICA DE DOENçA DE ALZHEIMER. A presente invenção refere-se a uso de modelos animais de distúrbios neurodegenerativos para estabelecimento de índices diagnósticos pré-clínicos e terapêuticos, e para métodos de seleção para identificar terapias pré-clínicas eficazes.
BRPI0517672-7A 2004-11-05 2005-11-03 modalidades de formação de imagens para seleção terapêutica de doença de alzheimer BRPI0517672A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62516204P 2004-11-05 2004-11-05
PCT/US2005/039865 WO2006052691A2 (en) 2004-11-05 2005-11-03 Pet and magnetic resonance for screening alzheimer's disease therapeutics

Publications (1)

Publication Number Publication Date
BRPI0517672A true BRPI0517672A (pt) 2008-10-14

Family

ID=36129750

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0517672-7A BRPI0517672A (pt) 2004-11-05 2005-11-03 modalidades de formação de imagens para seleção terapêutica de doença de alzheimer

Country Status (9)

Country Link
US (1) US20060117397A1 (pt)
EP (1) EP1807119A2 (pt)
JP (1) JP2008519282A (pt)
CN (1) CN101072591A (pt)
AU (1) AU2005304931A1 (pt)
BR (1) BRPI0517672A (pt)
CA (1) CA2586220A1 (pt)
MX (1) MX2007005317A (pt)
WO (1) WO2006052691A2 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9017724B2 (en) 2004-02-24 2015-04-28 The General Hospital Corporation Catalytic radiofluorination
US8257680B1 (en) 2004-02-24 2012-09-04 The General Hospital Corporation Catalytic radiofluorination
NZ563888A (en) * 2005-05-17 2009-11-27 Satori Pharmaceuticals Inc Compounds isolated from black cohosh root that are useful for treating neurodegenerative disorders by inhibiting amyloid-beta peptide production
US8150629B2 (en) * 2005-11-10 2012-04-03 In Silico Biosciences Method and apparatus for computer modeling of the interaction between and among cortical and subcortical areas in the human brain for the purpose of predicting the effect of drugs in psychiatric and cognitive diseases
JP5153114B2 (ja) * 2006-10-12 2013-02-27 知宏 千葉 新規のアルツハイマー病検出方法
JP5319121B2 (ja) * 2007-01-30 2013-10-16 株式会社東芝 診療支援システム及び診療支援装置
EP2120717A1 (en) * 2007-03-12 2009-11-25 National Institute of Radiological Sciences Pet visualization of amyloid-associated neuroinflammation in the brain
WO2008140779A2 (en) * 2007-05-10 2008-11-20 Trustees Of Columbia University In The City Of New York Methods for diagnosing diseases and evaluating treatments therefor using pet
US20090099783A1 (en) * 2007-06-08 2009-04-16 Barry Reisberg Stage Specific Prognostic In Vivo Markers of Brain Aging and Dementia
CL2007002908A1 (es) 2007-10-09 2008-05-30 Univ Concepcion Procedimiento electroquimico in vitro para evaluar capacidad neurotoxica de estructuras, principios activos y/o compuestos de interes en celulas vivas y que comprende medir y cuantificar los parametros electricos en membranas expuestas a dichos agreg
US8450466B2 (en) * 2008-03-21 2013-05-28 The General Hosptial Corporation Compounds and compositions for the detection and treatment of Alzheimer's disease and related disorders
EP2265174B1 (en) * 2008-04-04 2018-06-06 The Regents of The University of California Functionalized magnetic nanoparticles and methods of use thereof
US8593141B1 (en) 2009-11-24 2013-11-26 Hypres, Inc. Magnetic resonance system and method employing a digital squid
CA2795651A1 (en) * 2010-04-13 2011-10-20 Baxter International Inc. Use of ventricular enlargement rate in intravenous immunoglobulin treatment of alzheimer's disease
US8970217B1 (en) 2010-04-14 2015-03-03 Hypres, Inc. System and method for noise reduction in magnetic resonance imaging
DE102012209059B4 (de) * 2012-05-30 2024-05-02 Siemens Healthineers Ag Verfahren und Vorrichtung zur Bestimmung einer zeitlichen Änderung eines Biomarkers in einem Untersuchungsgebiet
US10203388B2 (en) 2016-01-04 2019-02-12 Toshiba Medical Systems Corporation Magnetic resonance imaging apparatus and magnetic resonance imaging method
CN114587323A (zh) * 2020-12-04 2022-06-07 安影科技（北京）有限公司 一种阿尔茨海默病脑血流灌注异常的测量方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE971033T1 (de) * 1991-01-21 2001-05-03 Imperial College Of Science, Technology & Medicine Prüfung und Modell für Alzheimers-Krankheit
DE1001019T1 (de) * 1993-10-27 2001-01-11 Athena Neurosciences Inc Transgene Tiere, die APP Allele mit der schwedischen Mutation beherbergen
JPH07132033A (ja) * 1993-11-12 1995-05-23 Hoechst Japan Ltd アルツハイマー病モデルトランスジェニック動物
US5877399A (en) * 1994-01-27 1999-03-02 Johns Hopkins University Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease
US6717031B2 (en) * 1995-06-07 2004-04-06 Kate Dora Games Method for selecting a transgenic mouse model of alzheimer's disease
US5894078A (en) * 1996-02-26 1999-04-13 Advanced Bioconcept, Inc. Transgenic mouse expressing C-100 app
US5849999A (en) * 1996-10-16 1998-12-15 The Mclean Hospital Corporation Transgenic non-human mice expressing Flag-APP-C100 protein develop alzheimer's disease brain morphology and behavior
US5898094A (en) * 1996-10-21 1999-04-27 University Of South Florida Transgenic mice expressing APPK670N,M671L and a mutant presenilin transgenes
US6284944B1 (en) * 1997-08-29 2001-09-04 Cephalon, Inc, Gene-targeted non-human mammal with a human fad presenilin mutation and generational offspring
US6175057B1 (en) * 1997-10-08 2001-01-16 The Regents Of The University Of California Transgenic mouse model of alzheimer's disease and cerebral amyloid angiopathy
US5846197A (en) * 1998-03-16 1998-12-08 Beth Israel Deaconess Medical Center Compensating for magnetization transfer effects in multislice and three-dimensional MRI blood flow mapping studies
US6664443B1 (en) * 1998-05-01 2003-12-16 Mayo Foundation For Medical Education And Research Pathogenic Tau mutations in transgenic mice
JP3980833B2 (ja) * 1998-08-20 2007-09-26 リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア βアミロイド斑及び神経原線維変化の標識方法
AU4078900A (en) * 1999-04-06 2000-10-23 Harrington Arthritis Research Center Methods for tracking the progression of alzheimer's disease and identifying treatments using transgenic mice
US7371920B2 (en) * 2000-06-20 2008-05-13 The Governing Council Of The University Of Toronto Transgenic mouse model of neurodegenerative disorders
US6593516B1 (en) * 2002-10-03 2003-07-15 Rico Corp. Holder for a musical instrument reed
JP2006519609A (ja) * 2003-03-12 2006-08-31 サマリタン・ファーマシューティカルズ・インコーポレイテッド 神経疾患擬態動物モデル

Also Published As

Publication number Publication date
WO2006052691A2 (en) 2006-05-18
CA2586220A1 (en) 2006-05-18
AU2005304931A1 (en) 2006-05-18
WO2006052691A3 (en) 2007-05-10
US20060117397A1 (en) 2006-06-01
JP2008519282A (ja) 2008-06-05
EP1807119A2 (en) 2007-07-18
MX2007005317A (es) 2007-06-11
CN101072591A (zh) 2007-11-14

Similar Documents

Publication Publication Date Title
BRPI0517672A (pt) modalidades de formação de imagens para seleção terapêutica de doença de alzheimer
Alexander et al. Increased aggression in males in transgenic Tg2576 mouse model of Alzheimer's disease
WO2005115136A3 (en) Transgenic models of alzheimer’s disease and uses thereof in the treatment of a variety of neurodegenerative diseases
Kukolja et al. Noradrenergic-glucocorticoid modulation of emotional memory encoding in the human hippocampus
Hefendehl et al. Long-term in vivo imaging of β-amyloid plaque appearance and growth in a mouse model of cerebral β-amyloidosis
CR20150016A (es) Anticuerpo monoclonal
CY1112737T1 (el) Ισοτοπικα σεσημασμενες ενωσεις βενζοfuran σαν παραγοντες απεικονισης για πρωτεϊνες δημιουργιας αμυλοειδους (αμυloid)
BRPI0511379A (pt) método para realizar uma análise cefalométrica e/ou uma análise antropométrica, método para derivar um planejamento de informação para reposicionamento de um fragmento ósseo, dispositivo para análise cefalométrica e/ou análise antropométrica e programa executável em um dispositivo contendo instruções
WO2008048410A3 (en) Diagnostic methods and genetic markers for alzheimer disease
DE602004028920D1 (de) Per
Raudino Non-cognitive symptoms and related conditions in the Alzheimer’s disease: a literature review
ES2414872T8 (es) Terapia combinada para la prevención o tratamiento de la enfermedad de Alzheimer y kit correspondiente
WO2006002541A8 (en) Non-invasive joint evaluation
Morton Large-brained animal models of Huntington’s disease: sheep
Zimmer et al. In vivo tracking of tau pathology using positron emission tomography (PET) molecular imaging in small animals
Sontheimer A portable digital microphotography unit for rapid documentation of periungual nailfold capillary changes in autoimmune connective tissue diseases.
ATE541923T1 (de) Transgener c. elegans als modellorganismus für untersuchungen zur alzheimer'schen krankheit
GB2431348B (en) Agents and methods for early diagnosis and monitoring of alzheimer's disease and other neurological disorders
Kraeuter et al. Neuropsychiatric sequelae of early nutritional modifications: a beginner’s guide to behavioral analysis
CY1110788T1 (el) Διαγονιδιακα ζωα τα οποια παρουσιαζουν σημαντικες διαταραχες σχετικες με την νοσο alzheimer
WO2006134128A3 (en) Diagnostic and therapeutic target adarb2 proteins for neurodegenerative diseases
Tijssen et al. Kinematic gait characteristics of straight line walk in clinically sound dairy cows
EP1769089A4 (en) METHODS AND COMPOSITIONS FOR PRE-SYMPTOMATIC OR POST-SYMPTOMATIC DIAGNOSIS OF ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS
IL172690A0 (en) Methods for the diagnosis and prognosis of alzheimer's disease
RU2007105389A (ru) Способ диагностики опухолей задней черепной ямки

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.